Argus analyst David Toung downgraded Bio-Techne Corp. (NASDAQ: TECH) from Buy to Sell.For an analyst ratings summary and ratings history on Bio-Techne ...
Analysts set a USD 68.92 target on October 14, 2026. Bio-Techne stock costs EUR 64.71 on October 15, 2026, up 0.05 percent on Nasdaq. The stock sat 0.22 percent below its 52-week high on October 15, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results